BIO5 Latest News

  • A $1.5 million grant from the National Science Foundation will allow UA researchers to unlock the genetic code of West African cultivated rice—and along the way to gain knowledge that could help commercial rice strains to better withstand dwindling resources, a changing climate, and increased demand.
     

  • Carol Gregorio, PhD, a nationally recognized leader in heart muscle research, has been appointed head of the Department of Cell Biology and Anatomy at The University of Arizona College of Medicine in Tucson. Dr. Gregorio served as interim department head since 2008.

  • The White House announced July 9, 2009 that a University of Arizona (UA) researcher won a top national honor for her work on a potentially deadly virus that affects the majority of people on Earth.

    Felicia Goodrum—the only Arizona-based recipient of the award—received the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on young professionals in the early stages of their independent research careers. Dr. Goodrum is an assistant professor in the Department of Immunobiology in the College of Medicine and the Department of Molecular and Cellular Biology in the College of Science. She is a member of the BIO5 Institute and Arizona Cancer Center.

  • University of Arizona (UA) neuroscientist Carol Barnes has been named associate director of the BIO5 Institute and UA biomedical engineer Jennifer Barton has been named assistant director. Pharmacy professor Laurence Hurley is stepping down as associate director. His lab will remain in BIO5 and he will continue to provide leadership to BIO5’s Drug Discovery and Development Initiative.

    “I appreciate Dr. Hurley’s contributions to BIO5 and welcome Dr. Barnes and Dr. Barton. They are brilliant scientists who understand the interdisciplinary nature of BIO5’s research agenda. They lead programs in their respective areas that connect people from different disciplines and backgrounds and they bring new leadership capacity to BIO5. I look forward to their contributions,” says BIO5 Interim Director Fernando D. Martinez.

Syndicate content